Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A new paper in BJU International offers an analysis of data on the effectiveness and safety of focal cryotherapy (partial cryoablation of the prostate) as a first-line treatment for localized prostate cancer from the national Cryo On-Line Database (COLD) registry collected between 1997 and 2007.
Filed under: Management, Treatment | Tagged: COLD registry, cryotherapy, focal, outcome | Leave a Comment »
The potential of high-intensity focused ultrasound (HIFU) as a form of focal therapy for treatment of cancer isolated to a portion of the prostate as opposed to treatment of the entire prostate has been recognized for a considerable period of time. However, limited data are available so far on the outcomes of men treated with [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: complication, focal, HIFU, high-intensity focused ultrasound, outcome, recurrence | 5 Comments »
In this weekend’s prostate cancer news reports, we have addressed recent publications on: A SNP that may be specifically linked to risk for prostate cancer in African Americans The need for extended biopsies in men with larger prostates who are considering focal treatment for prostate cancer A possible association between diabetes, race, obesity, and risk [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: African American, age, biopsy, brachytherapy, diabetes, focal, hormone therapy, mortality, neoadjuvant, obesity, race, single nucleotide polymorphism, SNP, Treatment | Leave a Comment »
Today’s news reports include items on: Risk for prostate cancer Patient decisions about sexual functionality and prostate cancer treatment Whole gland and focal cryotherapy Testosterone replacement after prostate cancer therapy and other items.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: cryotherapy, decision process, focal, patient, risk, sexual function, testosterone replacement, Trelstar, TRT, UroCool™ | Leave a Comment »
A review article by Polascik et al. in this month’s issue of Oncology addresses the potential of third-generation cryosurgical technology as a method to treat localized prostate cancer by freezing only targeted areas of the gland as opposed to the entire prostate.
Filed under: Management, Treatment | Tagged: cancer, cryosurgery, cryotherapy, focal, localized, prostate | 4 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site